APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ion Channel Modulators

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ion Channel Modulators Market Outlook and Growth Opportunities 2026

21 December 2025207 pages

Choose your research edition.

Industry ResearchIon Channel Modulators Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Ion Channel Modulators Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ion Channel Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ion Channel Modulators Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Ion Channel Modulators Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Ion Channel Modulators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ion Channel Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ion Channel Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ion Channel Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ion Channel Modulators market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ion Channel Modulators market include Sanofi (France), Pfizer, Inc. (US), GlaxoSmithKline Plc. (UK), AstraZeneca (UK), Zalicus, Inc. (US), Xention Limited (UK), Targacept, Inc. (US), Parion Sciences, Inc. (US) and Novartis AG (Switzerland), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ion Channel Modulators market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ion Channel Modulators and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ion Channel Modulators revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ion Channel Modulators market.

Ion Channel Modulators Segment by Company

Sanofi (France)

Pfizer, Inc. (US)

GlaxoSmithKline Plc. (UK)

AstraZeneca (UK)

Zalicus, Inc. (US)

Xention Limited (UK)

Targacept, Inc. (US)

Parion Sciences, Inc. (US)

Novartis AG (Switzerland)

Neusentis, Inc. (US)

NeuroSearch A/S (Denmark)

Nanion Technologies GmbH (Germany)

flyion GmbH (Germany)

Evotec AG (Germany)

Cytocentrics AG (Germany)

Convergence Pharmaceuticals Limited (UK)

Cellectricon AB (Sweden)

CalciMedica, Inc. (US)

Aurora Biomed, Inc. (Canada)

Ion Channel Modulators Segment by Type

Channel Blockers

Channel Openers

Ion Channel Modulators Segment by Application

Clinical Trials

Hospital

Other

Ion Channel Modulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ion Channel Modulators status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ion Channel Modulators key companies, revenue, market share, and recent developments.

3. To split the Ion Channel Modulators breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ion Channel Modulators market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ion Channel Modulators significant trends, drivers, influence factors in global and regions.

6. To analyze Ion Channel Modulators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ion Channel Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ion Channel Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ion Channel Modulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ion Channel Modulators industry.

Chapter 3: Detailed analysis of Ion Channel Modulators company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ion Channel Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ion Channel Modulators in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ion Channel Modulators Industry Trends Table 2. Ion Channel Modulators Industry Drivers Table 3. Ion Channel Modulators Industry Opportunities and Challenges Table 4. Ion Channel Modulators Industry Restraints Table 5. Global Ion Channel Modulators Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ion Channel Modulators Revenue Share by Company (2021-2026) Table 7. Global Ion Channel Modulators Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ion Channel Modulators Key Company Manufacturing Base & Headquarters Table 9. Global Ion Channel Modulators Company, Product Type & Application Table 10. Global Ion Channel Modulators Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ion Channel Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Channel Blockers Table 15. Significant Companies of Channel Openers Table 16. Global Ion Channel Modulators Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Ion Channel Modulators Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Ion Channel Modulators Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Ion Channel Modulators Sales Value Share by Type (2021-2026) Table 20. Global Ion Channel Modulators Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinical Trials Table 22. Significant Companies of Hospital Table 23. Significant Companies of Other Table 24. Global Ion Channel Modulators Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ion Channel Modulators Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Ion Channel Modulators Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Ion Channel Modulators Sales Value Share by Application (2021-2026) Table 28. Global Ion Channel Modulators Sales Value Share by Application (2027-2032) Table 29. Global Ion Channel Modulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Ion Channel Modulators Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Ion Channel Modulators Sales Value Share by Region (2021-2026) Table 32. Global Ion Channel Modulators Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Ion Channel Modulators Sales Value Share by Region (2027-2032) Table 34. Global Ion Channel Modulators Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Ion Channel Modulators Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Ion Channel Modulators Sales Value Market Share by Country (2021-2026) Table 37. Global Ion Channel Modulators Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Ion Channel Modulators Sales Value Market Share by Country (2027-2032) Table 39. Sanofi (France) Company Information Table 40. Sanofi (France) Business Overview Table 41. Sanofi (France) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Sanofi (France) Ion Channel Modulators Product Portfolio Table 43. Sanofi (France) Recent Development Table 44. Pfizer, Inc. (US) Company Information Table 45. Pfizer, Inc. (US) Business Overview Table 46. Pfizer, Inc. (US) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Pfizer, Inc. (US) Ion Channel Modulators Product Portfolio Table 48. Pfizer, Inc. (US) Recent Development Table 49. GlaxoSmithKline Plc. (UK) Company Information Table 50. GlaxoSmithKline Plc. (UK) Business Overview Table 51. GlaxoSmithKline Plc. (UK) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. GlaxoSmithKline Plc. (UK) Ion Channel Modulators Product Portfolio Table 53. GlaxoSmithKline Plc. (UK) Recent Development Table 54. AstraZeneca (UK) Company Information Table 55. AstraZeneca (UK) Business Overview Table 56. AstraZeneca (UK) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. AstraZeneca (UK) Ion Channel Modulators Product Portfolio Table 58. AstraZeneca (UK) Recent Development Table 59. Zalicus, Inc. (US) Company Information Table 60. Zalicus, Inc. (US) Business Overview Table 61. Zalicus, Inc. (US) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Zalicus, Inc. (US) Ion Channel Modulators Product Portfolio Table 63. Zalicus, Inc. (US) Recent Development Table 64. Xention Limited (UK) Company Information Table 65. Xention Limited (UK) Business Overview Table 66. Xention Limited (UK) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Xention Limited (UK) Ion Channel Modulators Product Portfolio Table 68. Xention Limited (UK) Recent Development Table 69. Targacept, Inc. (US) Company Information Table 70. Targacept, Inc. (US) Business Overview Table 71. Targacept, Inc. (US) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Targacept, Inc. (US) Ion Channel Modulators Product Portfolio Table 73. Targacept, Inc. (US) Recent Development Table 74. Parion Sciences, Inc. (US) Company Information Table 75. Parion Sciences, Inc. (US) Business Overview Table 76. Parion Sciences, Inc. (US) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Parion Sciences, Inc. (US) Ion Channel Modulators Product Portfolio Table 78. Parion Sciences, Inc. (US) Recent Development Table 79. Novartis AG (Switzerland) Company Information Table 80. Novartis AG (Switzerland) Business Overview Table 81. Novartis AG (Switzerland) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novartis AG (Switzerland) Ion Channel Modulators Product Portfolio Table 83. Novartis AG (Switzerland) Recent Development Table 84. Neusentis, Inc. (US) Company Information Table 85. Neusentis, Inc. (US) Business Overview Table 86. Neusentis, Inc. (US) Ion Channel Modulators Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Neusentis, Inc. (US) Ion Channel Modulators Product Portfolio Table 88. Neusentis, Inc. (US) Recent Development Table 89. NeuroSearch A/S (Denmark) Company Information Table 90. NeuroSearch A/S (Denmark) Business Overview Table 91. NeuroSearch A/S (Denmark) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. NeuroSearch A/S (Denmark) Ion Channel Modulators Product Portfolio Table 93. NeuroSearch A/S (Denmark) Recent Development Table 94. Nanion Technologies GmbH (Germany) Company Information Table 95. Nanion Technologies GmbH (Germany) Business Overview Table 96. Nanion Technologies GmbH (Germany) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Nanion Technologies GmbH (Germany) Ion Channel Modulators Product Portfolio Table 98. Nanion Technologies GmbH (Germany) Recent Development Table 99. flyion GmbH (Germany) Company Information Table 100. flyion GmbH (Germany) Business Overview Table 101. flyion GmbH (Germany) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. flyion GmbH (Germany) Ion Channel Modulators Product Portfolio Table 103. flyion GmbH (Germany) Recent Development Table 104. Evotec AG (Germany) Company Information Table 105. Evotec AG (Germany) Business Overview Table 106. Evotec AG (Germany) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Evotec AG (Germany) Ion Channel Modulators Product Portfolio Table 108. Evotec AG (Germany) Recent Development Table 109. Cytocentrics AG (Germany) Company Information Table 110. Cytocentrics AG (Germany) Business Overview Table 111. Cytocentrics AG (Germany) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Cytocentrics AG (Germany) Ion Channel Modulators Product Portfolio Table 113. Cytocentrics AG (Germany) Recent Development Table 114. Convergence Pharmaceuticals Limited (UK) Company Information Table 115. Convergence Pharmaceuticals Limited (UK) Business Overview Table 116. Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Product Portfolio Table 118. Convergence Pharmaceuticals Limited (UK) Recent Development Table 119. Cellectricon AB (Sweden) Company Information Table 120. Cellectricon AB (Sweden) Business Overview Table 121. Cellectricon AB (Sweden) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Cellectricon AB (Sweden) Ion Channel Modulators Product Portfolio Table 123. Cellectricon AB (Sweden) Recent Development Table 124. CalciMedica, Inc. (US) Company Information Table 125. CalciMedica, Inc. (US) Business Overview Table 126. CalciMedica, Inc. (US) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. CalciMedica, Inc. (US) Ion Channel Modulators Product Portfolio Table 128. CalciMedica, Inc. (US) Recent Development Table 129. Aurora Biomed, Inc. (Canada) Company Information Table 130. Aurora Biomed, Inc. (Canada) Business Overview Table 131. Aurora Biomed, Inc. (Canada) Ion Channel Modulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Aurora Biomed, Inc. (Canada) Ion Channel Modulators Product Portfolio Table 133. Aurora Biomed, Inc. (Canada) Recent Development Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Ion Channel Modulators Product Image Figure 2. Global Ion Channel Modulators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ion Channel Modulators Market Size (2021-2032) & (US$ Million) Figure 4. Global Ion Channel Modulators Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Channel Blockers Image Figure 8. Channel Openers Image Figure 9. Global Ion Channel Modulators Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Ion Channel Modulators Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Ion Channel Modulators Sales Value Share by Type (2021-2032) Figure 12. Clinical Trials Image Figure 13. Hospital Image Figure 14. Other Image Figure 15. Global Ion Channel Modulators Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ion Channel Modulators Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ion Channel Modulators Sales Value Share by Application (2021-2032) Figure 18. Global Ion Channel Modulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Ion Channel Modulators Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Ion Channel Modulators Sales Value (2021-2032) & (US$ Million) Figure 21. North America Ion Channel Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Ion Channel Modulators Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Ion Channel Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Ion Channel Modulators Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Ion Channel Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Ion Channel Modulators Sales Value (2021-2032) & (US$ Million) Figure 27. South America Ion Channel Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Ion Channel Modulators Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Ion Channel Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Ion Channel Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Channel Blockers
  • Channel Openers
Applications
  • Clinical Trials
  • Hospital
  • Other
Companies covered
  • Sanofi (France)
  • Pfizer, Inc. (US)
  • GlaxoSmithKline Plc. (UK)
  • AstraZeneca (UK)
  • Zalicus, Inc. (US)
  • Xention Limited (UK)
  • Targacept, Inc. (US)
  • Parion Sciences, Inc. (US)
  • Novartis AG (Switzerland)
  • Neusentis, Inc. (US)
  • NeuroSearch A/S (Denmark)
  • Nanion Technologies GmbH (Germany)
  • flyion GmbH (Germany)
  • Evotec AG (Germany)
  • Cytocentrics AG (Germany)
  • Convergence Pharmaceuticals Limited (UK)
  • Cellectricon AB (Sweden)
  • CalciMedica, Inc. (US)
  • Aurora Biomed, Inc. (Canada)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ion Channel Modulators Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ion Channel Modulators Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ion Channel Modulators Market Dynamics
  1. 2.1 Ion Channel Modulators Industry Trends
  2. 2.2 Ion Channel Modulators Industry Drivers
  3. 2.3 Ion Channel Modulators Industry Opportunities and Challenges
  4. 2.4 Ion Channel Modulators Industry Restraints
3 Ion Channel Modulators Market by Company
  1. 3.1 Global Ion Channel Modulators Company Revenue Ranking in 2025
  2. 3.2 Global Ion Channel Modulators Revenue by Company (2021-2026)
  3. 3.3 Global Ion Channel Modulators Company Ranking (2024-2026)
  4. 3.4 Global Ion Channel Modulators Company Manufacturing Base and Headquarters
  5. 3.5 Global Ion Channel Modulators Company Product Type and Application
  6. 3.6 Global Ion Channel Modulators Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ion Channel Modulators Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ion Channel Modulators Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ion Channel Modulators Market by Type
  1. 4.1 Ion Channel Modulators Type Introduction
  2. 4.1.1 Channel Blockers
  3. 4.1.2 Channel Openers
  4. 4.2 Global Ion Channel Modulators Sales Value by Type
  5. 4.2.1 Global Ion Channel Modulators Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ion Channel Modulators Sales Value by Type (2021-2032)
  7. 4.2.3 Global Ion Channel Modulators Sales Value Share by Type (2021-2032)
5 Ion Channel Modulators Market by Application
  1. 5.1 Ion Channel Modulators Application Introduction
  2. 5.1.1 Clinical Trials
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Ion Channel Modulators Sales Value by Application
  6. 5.2.1 Global Ion Channel Modulators Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ion Channel Modulators Sales Value by Application (2021-2032)
  8. 5.2.3 Global Ion Channel Modulators Sales Value Share by Application (2021-2032)
6 Ion Channel Modulators Regional Value Analysis
  1. 6.1 Global Ion Channel Modulators Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ion Channel Modulators Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ion Channel Modulators Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ion Channel Modulators Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ion Channel Modulators Sales Value (2021-2032)
  7. 6.3.2 North America Ion Channel Modulators Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ion Channel Modulators Sales Value (2021-2032)
  10. 6.4.2 Europe Ion Channel Modulators Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ion Channel Modulators Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ion Channel Modulators Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ion Channel Modulators Sales Value (2021-2032)
  16. 6.6.2 South America Ion Channel Modulators Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ion Channel Modulators Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ion Channel Modulators Sales Value Share by Country, 2025 VS 2032
7 Ion Channel Modulators Country-level Value Analysis
  1. 7.1 Global Ion Channel Modulators Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ion Channel Modulators Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ion Channel Modulators Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ion Channel Modulators Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ion Channel Modulators Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ion Channel Modulators Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ion Channel Modulators Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi (France)
  2. 8.1.1 Sanofi (France) Company Information
  3. 8.1.2 Sanofi (France) Business Overview
  4. 8.1.3 Sanofi (France) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi (France) Ion Channel Modulators Product Portfolio
  6. 8.1.5 Sanofi (France) Recent Developments
  7. 8.2 Pfizer, Inc. (US)
  8. 8.2.1 Pfizer, Inc. (US) Company Information
  9. 8.2.2 Pfizer, Inc. (US) Business Overview
  10. 8.2.3 Pfizer, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer, Inc. (US) Ion Channel Modulators Product Portfolio
  12. 8.2.5 Pfizer, Inc. (US) Recent Developments
  13. 8.3 GlaxoSmithKline Plc. (UK)
  14. 8.3.1 GlaxoSmithKline Plc. (UK) Company Information
  15. 8.3.2 GlaxoSmithKline Plc. (UK) Business Overview
  16. 8.3.3 GlaxoSmithKline Plc. (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Plc. (UK) Ion Channel Modulators Product Portfolio
  18. 8.3.5 GlaxoSmithKline Plc. (UK) Recent Developments
  19. 8.4 AstraZeneca (UK)
  20. 8.4.1 AstraZeneca (UK) Company Information
  21. 8.4.2 AstraZeneca (UK) Business Overview
  22. 8.4.3 AstraZeneca (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca (UK) Ion Channel Modulators Product Portfolio
  24. 8.4.5 AstraZeneca (UK) Recent Developments
  25. 8.5 Zalicus, Inc. (US)
  26. 8.5.1 Zalicus, Inc. (US) Company Information
  27. 8.5.2 Zalicus, Inc. (US) Business Overview
  28. 8.5.3 Zalicus, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zalicus, Inc. (US) Ion Channel Modulators Product Portfolio
  30. 8.5.5 Zalicus, Inc. (US) Recent Developments
  31. 8.6 Xention Limited (UK)
  32. 8.6.1 Xention Limited (UK) Company Information
  33. 8.6.2 Xention Limited (UK) Business Overview
  34. 8.6.3 Xention Limited (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Xention Limited (UK) Ion Channel Modulators Product Portfolio
  36. 8.6.5 Xention Limited (UK) Recent Developments
  37. 8.7 Targacept, Inc. (US)
  38. 8.7.1 Targacept, Inc. (US) Company Information
  39. 8.7.2 Targacept, Inc. (US) Business Overview
  40. 8.7.3 Targacept, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Targacept, Inc. (US) Ion Channel Modulators Product Portfolio
  42. 8.7.5 Targacept, Inc. (US) Recent Developments
  43. 8.8 Parion Sciences, Inc. (US)
  44. 8.8.1 Parion Sciences, Inc. (US) Company Information
  45. 8.8.2 Parion Sciences, Inc. (US) Business Overview
  46. 8.8.3 Parion Sciences, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Parion Sciences, Inc. (US) Ion Channel Modulators Product Portfolio
  48. 8.8.5 Parion Sciences, Inc. (US) Recent Developments
  49. 8.9 Novartis AG (Switzerland)
  50. 8.9.1 Novartis AG (Switzerland) Company Information
  51. 8.9.2 Novartis AG (Switzerland) Business Overview
  52. 8.9.3 Novartis AG (Switzerland) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis AG (Switzerland) Ion Channel Modulators Product Portfolio
  54. 8.9.5 Novartis AG (Switzerland) Recent Developments
  55. 8.10 Neusentis, Inc. (US)
  56. 8.10.1 Neusentis, Inc. (US) Company Information
  57. 8.10.2 Neusentis, Inc. (US) Business Overview
  58. 8.10.3 Neusentis, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Neusentis, Inc. (US) Ion Channel Modulators Product Portfolio
  60. 8.10.5 Neusentis, Inc. (US) Recent Developments
  61. 8.11 NeuroSearch A/S (Denmark)
  62. 8.11.1 NeuroSearch A/S (Denmark) Company Information
  63. 8.11.2 NeuroSearch A/S (Denmark) Business Overview
  64. 8.11.3 NeuroSearch A/S (Denmark) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NeuroSearch A/S (Denmark) Ion Channel Modulators Product Portfolio
  66. 8.11.5 NeuroSearch A/S (Denmark) Recent Developments
  67. 8.12 Nanion Technologies GmbH (Germany)
  68. 8.12.1 Nanion Technologies GmbH (Germany) Company Information
  69. 8.12.2 Nanion Technologies GmbH (Germany) Business Overview
  70. 8.12.3 Nanion Technologies GmbH (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nanion Technologies GmbH (Germany) Ion Channel Modulators Product Portfolio
  72. 8.12.5 Nanion Technologies GmbH (Germany) Recent Developments
  73. 8.13 flyion GmbH (Germany)
  74. 8.13.1 flyion GmbH (Germany) Company Information
  75. 8.13.2 flyion GmbH (Germany) Business Overview
  76. 8.13.3 flyion GmbH (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  77. 8.13.4 flyion GmbH (Germany) Ion Channel Modulators Product Portfolio
  78. 8.13.5 flyion GmbH (Germany) Recent Developments
  79. 8.14 Evotec AG (Germany)
  80. 8.14.1 Evotec AG (Germany) Company Information
  81. 8.14.2 Evotec AG (Germany) Business Overview
  82. 8.14.3 Evotec AG (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Evotec AG (Germany) Ion Channel Modulators Product Portfolio
  84. 8.14.5 Evotec AG (Germany) Recent Developments
  85. 8.15 Cytocentrics AG (Germany)
  86. 8.15.1 Cytocentrics AG (Germany) Company Information
  87. 8.15.2 Cytocentrics AG (Germany) Business Overview
  88. 8.15.3 Cytocentrics AG (Germany) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cytocentrics AG (Germany) Ion Channel Modulators Product Portfolio
  90. 8.15.5 Cytocentrics AG (Germany) Recent Developments
  91. 8.16 Convergence Pharmaceuticals Limited (UK)
  92. 8.16.1 Convergence Pharmaceuticals Limited (UK) Company Information
  93. 8.16.2 Convergence Pharmaceuticals Limited (UK) Business Overview
  94. 8.16.3 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Convergence Pharmaceuticals Limited (UK) Ion Channel Modulators Product Portfolio
  96. 8.16.5 Convergence Pharmaceuticals Limited (UK) Recent Developments
  97. 8.17 Cellectricon AB (Sweden)
  98. 8.17.1 Cellectricon AB (Sweden) Company Information
  99. 8.17.2 Cellectricon AB (Sweden) Business Overview
  100. 8.17.3 Cellectricon AB (Sweden) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cellectricon AB (Sweden) Ion Channel Modulators Product Portfolio
  102. 8.17.5 Cellectricon AB (Sweden) Recent Developments
  103. 8.18 CalciMedica, Inc. (US)
  104. 8.18.1 CalciMedica, Inc. (US) Company Information
  105. 8.18.2 CalciMedica, Inc. (US) Business Overview
  106. 8.18.3 CalciMedica, Inc. (US) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CalciMedica, Inc. (US) Ion Channel Modulators Product Portfolio
  108. 8.18.5 CalciMedica, Inc. (US) Recent Developments
  109. 8.19 Aurora Biomed, Inc. (Canada)
  110. 8.19.1 Aurora Biomed, Inc. (Canada) Company Information
  111. 8.19.2 Aurora Biomed, Inc. (Canada) Business Overview
  112. 8.19.3 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aurora Biomed, Inc. (Canada) Ion Channel Modulators Product Portfolio
  114. 8.19.5 Aurora Biomed, Inc. (Canada) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst